Hoag Hospital

Irvine, California 92618

2 studies enrolling now · 4 studies all time

What they study most

Crohn Disease, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Moderately to Severely Active Crohn Disease, Ulcerative Colitis

Studies at this site

• Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission — Recruiting now
• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease — Recruiting now
• Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04) — Running, not enrolling
• Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) — Running, not enrolling